Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Bicycle Therapeutics (BCYC) Other Operating Expenses (2018 - 2025)

Bicycle Therapeutics (BCYC) has disclosed Other Operating Expenses for 5 consecutive years, with -$2.5 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Operating Expenses rose 2.29% year-over-year to -$2.5 million, compared with a TTM value of -$9.6 million through Sep 2025, down 48.18%, and an annual FY2024 reading of -$9.0 million, up 0.99% over the prior year.
  • Other Operating Expenses was -$2.5 million for Q3 2025 at Bicycle Therapeutics, down from -$2.3 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at -$3000.0 in Q3 2021 and bottomed at -$2.6 million in Q4 2024.
  • Average Other Operating Expenses over 3 years is -$2.0 million, with a median of -$2.3 million recorded in 2025.
  • Peak annual rise in Other Operating Expenses hit 2.29% in 2025, while the deepest fall reached 21.45% in 2025.
  • Year by year, Other Operating Expenses stood at -$3000.0 in 2021, then tumbled by 86033.33% to -$2.6 million in 2024, then increased by 4.3% to -$2.5 million in 2025.
  • Business Quant data shows Other Operating Expenses for BCYC at -$2.5 million in Q3 2025, -$2.3 million in Q2 2025, and -$2.2 million in Q1 2025.